Research summary, original research, 2022

Radiation safety awareness and practices amongst orthopaedic surgeons in Scotland

Snowden G, Jabbal M, Akhtar A. Scottish medical journal. 2022

Read the original paper

In plain language

In a survey of 72 orthopaedic surgeons in Scotland, all reported wearing lead aprons, but under half regularly wore thyroid shields and only 55% had completed radiation safety training, with junior trainees least trained.

At a glance

Type of study
Original research, Cross-sectional survey
Who was studied
Orthopedic surgeons, Trainees
Size
n = 72 orthopaedic surgeons (survey respondents)
Where
United Kingdom
Summary based on
the abstract

What it found

  • Only about half of respondents had completed a radiation safety course, with junior trainees far less likely than consultants or senior trainees.

    Key figures: 55% (n = 40) overall; junior trainees 29% (n = 6), consultants 82% (n = 23), senior trainees 48% (n = 11); p < 0.0001

  • All respondents reported always wearing lead aprons, but fewer than half frequently or always wore thyroid protection.

    Key figures: 100% aprons; 46.2% (n = 34) thyroid protection

  • Radiation training and knowledge varied considerably by seniority and across Scotland.

  • The survey covered 72 surgeons from 20 hospitals across all four Scottish deaneries.

    Key figures: 72 responses; 20 hospitals; 28 Consultants, 23 Senior trainees, 21 Junior trainees

Limits to keep in mind

Small self-reported online survey with unknown response rate and possible selection bias; back pain results are not reported in the abstract.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.